PURA Introduces New EVERx CBD Sports Water Bullet Bottles After Reaching $1 Million Sales Milestone
January 11 2019 - 10:41AM
InvestorsHub NewsWire
PURA Introduces New
EVERx CBD Sports Water Bullet
Bottles After Reaching $1 Million Sales
Milestone
Dallas, TX
-- January 11, 2019 --
Puration, Inc. (PURA) ("PURA") today introduced its all
new EVERx CBD Sport Water Bullet Bottles
to ring in the new year. EVERx has been undergoing an
all around
update after
reaching over a million dollars in annual sales. The
EVERx
logo has been
refreshed, with patented cannabis extraction partner Kali-Extracts
(KALY), the EVERx formula has been improved, and
with copacker partner Alkame Holdings, (ALKM) and their new state-of-the-art
bottling production line, EVERx now has an entirely new bottle.
Look for an announcement next week about an upcoming
live
event to celebrate
the $1 million sales milestone and introduce the all new
EVERx
CBD Sports Water.
The event will be hosted by the USMJ's
(USMJ) Miss USMJ Models featured in
the 2019 Miss USMJ Calendar on sale now at www.missusmj.com and www.etsy.com.
Puration
launched
the EVERx
CBD
Sports Waters in the spring of 2017.
The
company's sales grew 600% in the first year after the launch
of EVERx.
Kiwi
Strawberry and Lemon Lime flavors are now available in addition the
Original EVERx
CBD
Infused Sports Water. EVERx
has
more than twice the CBD of most CBD infused waters on the
market.
A
proprietary
technology enables EVERx
to
suspend more CBD than its competitors and still have a
crystal-clear appearance and a refreshing taste.
For
more information on Puration,
visit http://www.purationinc.com
Disclaimer/Safe
Harbor:
This news
release contains forward-looking statements within the meaning of
the Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include the
expectation that any of the companies mentioned herein will achieve
significant sales, the failure to meet schedule or performance
requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the
emergence of competitors with greater financial resources and the
impact of competitive pricing. In the light of these uncertainties,
the forward-looking events referred to in this release might not
occur. These statements have not been evaluated by the Food and
Drug Administration. These products are not intended to diagnose,
treat, cure, or prevent any disease.
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800)
861-1350
Kali (CE) (USOTC:KALY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Kali (CE) (USOTC:KALY)
Historical Stock Chart
From Sep 2023 to Sep 2024